Heterodimeric Photosensitizer as Radical Generators to Promoting Type I Photodynamic Conversion for Hypoxic Tumor Therapy

generation. The resultant BSA@NBSSe nanoparticles demonstrate successful tumor-targeting PDT capability. This work provides an appealing avenue to convert ROS generation from the type II pathway to the type I pathway for efficient cancer phototherapy in hypoxia.